JNK antibody (pThr183, pTyr185) (FITC)
Quick Overview for JNK antibody (pThr183, pTyr185) (FITC) (ABIN732375)
Target
See all JNK (MAPK8) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - pThr183, pTyr185
 - 
                                            
Cross-Reactivity
 - Dog, Human, Mouse, Rabbit, Rat
 - 
                                            
Predicted Reactivity
 - Cow,Pig
 - 
                                            
Purification
 - Purified by Protein A.
 - 
                                            
Immunogen
 - KLH conjugated synthetic phosphopeptide derived from human JNK1 around the phosphorylation site of Thr183/Tyr185
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Concentration
 - 1 μg/μL
 - 
                                            
Buffer
 - Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
 - 
                                            
Storage
 - -20 °C
 - 
                                            
Storage Comment
 - Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
 - 
                                            
Expiry Date
 - 12 months
 
 - 
                                            
 - 
    
- 
                                            : "Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes."    in: Cancer medicine, Vol. 5, Issue 11, pp. 3223-3234, (2016)         (PubMed).        
 
 - 
                                            : "Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes."    in: Cancer medicine, Vol. 5, Issue 11, pp. 3223-3234, (2016)         (PubMed).        
 - 
    
- JNK (MAPK8) (Mitogen-Activated Protein Kinase 8 (MAPK8))
 - 
                                            
Alternative Name
 - JNK1 , 2 , 3
 - 
                                            
Background
 - 
                        
Synonyms: JNK, JNK1, PRKM8, SAPK1, JNK-46, JNK1A2, SAPK1c, JNK21B1/2, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, MAPK8
Background: JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.
 - 
                                            
Gene ID
 - 5599
 - 
                                            
UniProt
 - P45983
 - 
                                            
Pathways
 - MAPK Signaling, WNT Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, S100 Proteins
 
Target
 -